- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
FDA issues ibuprofen/aspirin warning
The FDA has notified consumers and healthcare professionals that taking ibuprofen for pain relief and aspirin at the same time may interfere with the benefits of aspirin taken for the heart.
The FDA has notified consumers and healthcare professionals that taking ibuprofen for pain relief and aspirin at the same time may interfere with the benefits of aspirin taken for the heart. Ibuprofen can interfere with the antiplatelet effect of low-dose aspirin (81 mg per day), and that may render aspirin less effective when used for cardio protection and stroke prevention. Although it is all right to use ibuprofen and aspirin together, the FDA recommends that consumers contact their healthcare professional for more information on the timing of taking these two medicines, so that both can be effective. The summary can be found at www.fda.gov/medwatch/safety/2006/safety06.htm#aspirin.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
